AFLAflac

$117.43

$100.1452 weeks$129.52

Price

$117.43+17%1Y

1M-5.6%1Y+17%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average

8/10

Value51

Quality83

Momentum43

Growth80

Strongest Quality, weakest Momentum · ranked vs Financial Services peers. The five questions below judge the company on its own terms.

What they do

Aflac Japan is the principal contributor to the Parent Company's consolidated earnings and the largest insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. For information on Aflac Japan's operating results, see the Aflac Japan Segment section of Item 7. MD&A.

In the company’s own words · 10-K filed Feb 25, 2026 · SEC EDGAR

P/E (TTM)12.6

Market Cap$58.77B

1Y Return+17%

5Y Return+139%

Business segments

Q1 2026 · $4.24B

The company’s own SEC segment disclosure.

Aflac Japan$2.17B51%
Aflac US$1.78B42%
Corporate And Other$292.0M7%

Aflac (AFL) reported revenue of $4.12B in Q2 2026 (quarter ended June 30, 2026), down 1.0% from the same quarter a year earlier. That came with net income of $825M (20% of revenue). For the full year FY2025, revenue was $17.2B (−9.3% year on year) and net income $3.65B. Its largest segment in 2026-Q1 was Aflac Japan at $2.17B, 51% of the disclosed total, just ahead of Aflac US at 42%.

Raw charts

9 series · TTM

As reported to the SEC, without any scoring.

Insurance - Life

Ranks #4 of 13 by Smart Score

Manulife Financial Corporation